Phase 1 study of OKI-179, an oral class 1-selective depsipeptide HDAC inhibitor, in patients with advanced solid tumors: Final results. Phase Ia study of CBP-1008, a bi-specific ligand drug conjugate ...
Current kidney organoids model development and diseases of the nephron but not the contiguous epithelial network of the kidney’s collecting duct (CD) system. Here, we report the generation of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results